Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Nature Reviews. Neurology
|
August 26, 2015
Type I interferon dysregulation and neurological disease
Sarah McGlasson, Alexa Jury, Andrew Jackson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 25, 2019
Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies
Sarah-Jane Martin, Sarah McGlasson, David Hunt, et al.
Frontiers in Immunology
|
June 22, 2018
Neurological Disease in Lupus: Toward a Personalized Medicine Approach
Sarah McGlasson, Stewart Wiseman, Joanna Wardlaw, et al.
Wellcome Open Research
|
June 10, 2024
Phenotypes associated with genetic determinants of type I interferon regulation in the UK Biobank: a protocol
Bastien Rioux, Michael Chong, Rosie Walker, et al.
Nature Communications
|
January 27, 2026
Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK Biobank
Bastien Rioux, Sarah McGlasson, Deborah Forbes, et al.
Wellcome Open Research
|
February 2, 2018
Rare variants of the 3'-5' DNA exonuclease <i>TREX1</i> in early onset small vessel stroke
Sarah McGlasson, Kristiina Rannikmäe, Steven Bevan, et al.
Brain : a Journal of Neurology
|
June 6, 2025
Misdirected yet intact TREX1 exonuclease activity causes human cerebral and systemic small vessel disease
Sarah McGlasson, Katy Reid, Anna Klingseisen, et al.
Immunity
|
June 15, 2024
The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathies
Barney Viengkhou, Emina Hayashida, Sarah McGlasson, et al.
The Lancet. Rheumatology
|
July 2, 2026
Interferon-α as a precision medicine tool in Sjögren's disease: a cohort and experimental medicine study
Deborah Forbes, Ivana Jorgacevic, Jessica Tarn, et al.
Blood
|
September 25, 2016
Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature
David Kavanagh, Sarah McGlasson, Alexa Jury, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Nature Reviews. Neurology
|
August 26, 2015
Type I interferon dysregulation and neurological disease
Sarah McGlasson, Alexa Jury, Andrew Jackson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 25, 2019
Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies
Sarah-Jane Martin, Sarah McGlasson, David Hunt, et al.
Frontiers in Immunology
|
June 22, 2018
Neurological Disease in Lupus: Toward a Personalized Medicine Approach
Sarah McGlasson, Stewart Wiseman, Joanna Wardlaw, et al.
Wellcome Open Research
|
June 10, 2024
Phenotypes associated with genetic determinants of type I interferon regulation in the UK Biobank: a protocol
Bastien Rioux, Michael Chong, Rosie Walker, et al.
Nature Communications
|
January 27, 2026
Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK Biobank
Bastien Rioux, Sarah McGlasson, Deborah Forbes, et al.
Wellcome Open Research
|
February 2, 2018
Rare variants of the 3'-5' DNA exonuclease <i>TREX1</i> in early onset small vessel stroke
Sarah McGlasson, Kristiina Rannikmäe, Steven Bevan, et al.
Brain : a Journal of Neurology
|
June 6, 2025
Misdirected yet intact TREX1 exonuclease activity causes human cerebral and systemic small vessel disease
Sarah McGlasson, Katy Reid, Anna Klingseisen, et al.
Immunity
|
June 15, 2024
The brain microvasculature is a primary mediator of interferon-α neurotoxicity in human cerebral interferonopathies
Barney Viengkhou, Emina Hayashida, Sarah McGlasson, et al.
The Lancet. Rheumatology
|
July 2, 2026
Interferon-α as a precision medicine tool in Sjögren's disease: a cohort and experimental medicine study
Deborah Forbes, Ivana Jorgacevic, Jessica Tarn, et al.
Blood
|
September 25, 2016
Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature
David Kavanagh, Sarah McGlasson, Alexa Jury, et al.
Page
of 2